These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 20843788

  • 1. Activin A binds to perlecan through its pro-region that has heparin/heparan sulfate binding activity.
    Li S, Shimono C, Norioka N, Nakano I, Okubo T, Yagi Y, Hayashi M, Sato Y, Fujisaki H, Hattori S, Sugiura N, Kimata K, Sekiguchi K.
    J Biol Chem; 2010 Nov 19; 285(47):36645-55. PubMed ID: 20843788
    [Abstract] [Full Text] [Related]

  • 2. Nephronectin binds to heparan sulfate proteoglycans via its MAM domain.
    Sato Y, Shimono C, Li S, Nakano I, Norioka N, Sugiura N, Kimata K, Yamada M, Sekiguchi K.
    Matrix Biol; 2013 Apr 24; 32(3-4):188-95. PubMed ID: 23357641
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The C-terminal domain V of perlecan promotes beta1 integrin-mediated cell adhesion, binds heparin, nidogen and fibulin-2 and can be modified by glycosaminoglycans.
    Brown JC, Sasaki T, Göhring W, Yamada Y, Timpl R.
    Eur J Biochem; 1997 Nov 15; 250(1):39-46. PubMed ID: 9431988
    [Abstract] [Full Text] [Related]

  • 6. Structural basis of glycosaminoglycan modification and of heterotypic interactions of perlecan domain V.
    Friedrich MV, Göhring W, Mörgelin M, Brancaccio A, David G, Timpl R.
    J Mol Biol; 1999 Nov 19; 294(1):259-70. PubMed ID: 10556044
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Mapping of binding sites for nidogens, fibulin-2, fibronectin and heparin to different IG modules of perlecan.
    Hopf M, Göhring W, Mann K, Timpl R.
    J Mol Biol; 2001 Aug 17; 311(3):529-41. PubMed ID: 11493006
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The leucine-rich repeat protein PRELP binds perlecan and collagens and may function as a basement membrane anchor.
    Bengtsson E, Mörgelin M, Sasaki T, Timpl R, Heinegård D, Aspberg A.
    J Biol Chem; 2002 Apr 26; 277(17):15061-8. PubMed ID: 11847210
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of glycosaminoglycan modification of perlecan domain I by site-directed mutagenesis changes protease sensitivity and laminin-1 binding activity.
    Sasaki T, Costell M, Mann K, Timpl R.
    FEBS Lett; 1998 Sep 18; 435(2-3):169-72. PubMed ID: 9762901
    [Abstract] [Full Text] [Related]

  • 13. Site-directed mutagenesis of a putative heparin binding domain of avian lipoprotein lipase.
    Berryman DE, Bensadoun A.
    J Biol Chem; 1993 Feb 15; 268(5):3272-6. PubMed ID: 8429005
    [Abstract] [Full Text] [Related]

  • 14. Identification of a heparin binding domain in the N-terminal cleavage site of pro-islet amyloid polypeptide. Implications for islet amyloid formation.
    Park K, Verchere CB.
    J Biol Chem; 2001 May 18; 276(20):16611-6. PubMed ID: 11145957
    [Abstract] [Full Text] [Related]

  • 15. Perlecan is responsible for thrombospondin 1 binding on the cell surface of cultured porcine endothelial cells.
    Vischer P, Feitsma K, Schön P, Völker W.
    Eur J Cell Biol; 1997 Aug 18; 73(4):332-43. PubMed ID: 9270876
    [Abstract] [Full Text] [Related]

  • 16. The relationship between perlecan and dystroglycan and its implication in the formation of the neuromuscular junction.
    Peng HB, Ali AA, Daggett DF, Rauvala H, Hassell JR, Smalheiser NR.
    Cell Adhes Commun; 1998 Sep 18; 5(6):475-89. PubMed ID: 9791728
    [Abstract] [Full Text] [Related]

  • 17. The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases.
    Whitelock JM, Murdoch AD, Iozzo RV, Underwood PA.
    J Biol Chem; 1996 Apr 26; 271(17):10079-86. PubMed ID: 8626565
    [Abstract] [Full Text] [Related]

  • 18. Heparanase degrades syndecan-1 and perlecan heparan sulfate: functional implications for tumor cell invasion.
    Reiland J, Sanderson RD, Waguespack M, Barker SA, Long R, Carson DD, Marchetti D.
    J Biol Chem; 2004 Feb 27; 279(9):8047-55. PubMed ID: 14630925
    [Abstract] [Full Text] [Related]

  • 19. An interaction between basement membrane and Alzheimer amyloid precursor proteins suggests a role in the pathogenesis of Alzheimer's disease.
    Narindrasorasak S, Altman RA, Gonzalez-DeWhitt P, Greenberg BD, Kisilevsky R.
    Lab Invest; 1995 Mar 27; 72(3):272-82. PubMed ID: 7898047
    [Abstract] [Full Text] [Related]

  • 20. Endothelial cells interact with the core protein of basement membrane perlecan through beta 1 and beta 3 integrins: an adhesion modulated by glycosaminoglycan.
    Hayashi K, Madri JA, Yurchenco PD.
    J Cell Biol; 1992 Nov 27; 119(4):945-59. PubMed ID: 1385448
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.